Going forward, the federal response to the COVID-19 pandemic will require centralized decision-making around how to equitably allocate, and reallocate, limited supplies of ventilators to states in need. Projections from the Institute for Health Metrics and Evaluation at the University of Washington, which assume that all states will institute strict social distancing practices and maintain them until after infections peak, show states will hit their peak demand at different time points throughout the months of April and May. Many states are predicted to experience a significant gap in ICU capacity, and similar, if not greater, gaps in ventilator capacity, with the time point at which needs will begin to exceed current capacity varying by state [8].
We present a stochastic optimization model for allocating and sharing a critical resource in the case of a pandemic. The demand for different entities peaks at different times, and an initial inventory for a central agency is to be allocated. The entities (states) may share the critical resource with a different state under a risk-averse condition. The model is applied to study the allocation of ventilator inventory in the COVID-19 pandemic by FEMA to different US states. Findings suggest that if less than 60% of the ventilator inventory is available for non-COVID-19 patients, FEMA's stockpile of 20,000 ventilators (as of 03/23/2020) would be nearly adequate to meet the projected needs in slightly above average demand scenarios. However, when more than 75% of the available ventilator inventory must be reserved for non-COVID-19 patients, various degrees of shortfall are expected. In a severe case, where the demand is concentrated in the top-most quartile of the forecast confidence interval and states are not willing to share their stockpile of ventilators, the total shortfall over the planning horizon (till 05/31/20) is about 232,000 ventilator days, with a peak shortfall of 17,200 ventilators on
The concepts of risk aversion, chance-constrained optimization, and robust optimization have developed significantly over the last decade. The statistical learning community has also witnessed a rapid theoretical and applied growth by relying on these concepts. A modeling framework, called distributionally robust optimization (DRO), has recently received significant attention in both the operations research and statistical learning communities. This paper surveys main concepts and contributions to DRO, and relationships with robust optimization, risk aversion, chance-constrained optimization, and function regularization. Various approaches to model the distributional ambiguity and their calibrations are discussed. The paper also describes the main solution techniques used to the solve the resulting optimization problems.
We study multistage distributionally robust optimization (DRO) to hedge against ambiguity in quantifying the underlying uncertainty of a problem. Recognizing that not all the realizations and scenario paths might have an "effect" on the optimal value, we investigate the question of how to define and identify critical scenarios for nested multistage DRO problems. Our analysis extends the work of Rahimian, Bayraksan, and Homem-de-Mello [Math. Program. 173(1-2): 393-430, 2019], which was in the context of a static/two-stage setting, to the multistage setting. To this end, we define the notions of effectiveness of scenario paths and the conditional effectiveness of realizations along a scenario path for a general class of multistage DRO problems. We then propose easy-to-check conditions to identify the effectiveness of scenario paths in the multistage setting when the distributional ambiguity is modeled via the total variation distance. Numerical results show that these notions provide useful insight on the underlying uncertainty of the problem.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.